Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Development of a multimarker assay for early detection of ovarian cancer.

Yurkovetsky Z, Skates S, Lomakin A, Nolen B, Pulsipher T, Modugno F, Marks J, Godwin A, Gorelik E, Jacobs I, Menon U, Lu K, Badgwell D, Bast RC Jr, Lokshin AE.

J Clin Oncol. 2010 May 1;28(13):2159-66. doi: 10.1200/JCO.2008.19.2484. Epub 2010 Apr 5.

2.

Do serum biomarkers really measure breast cancer?

Jesneck JL, Mukherjee S, Yurkovetsky Z, Clyde M, Marks JR, Lokshin AE, Lo JY.

BMC Cancer. 2009 May 28;9:164. doi: 10.1186/1471-2407-9-164.

3.

Hormones as biomarkers: practical guide to utilizing luminex technologies for biomarker research.

Linkov F, Yurkovetsky Z, Lokshin A.

Methods Mol Biol. 2009;520:129-41. doi: 10.1007/978-1-60327-811-9_9.

PMID:
19381951
4.

Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases.

Linkov F, Ferris RL, Yurkovetsky Z, Marrangoni A, Velikokhatnaya L, Gooding W, Nolan B, Winans M, Siegel ER, Lokshin A, Stack BC Jr.

Proteomics Clin Appl. 2008 Oct 10;2(12):1575-1585.

5.

Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors.

Linkov F, Edwards R, Balk J, Yurkovetsky Z, Stadterman B, Lokshin A, Taioli E.

Eur J Cancer. 2008 Aug;44(12):1632-44. doi: 10.1016/j.ejca.2008.05.001. Epub 2008 May 29. Review.

PMID:
18514507
6.

Endometrial cancer: multiplexed Luminex approaches for early detection.

Linkov F, Yurkovetsky Z, Taioli E, Havrilesky LJ, Maxwell GL, Lokshin A.

Expert Opin Med Diagn. 2008 May;2(5):527-37. doi: 10.1517/17530059.2.5.527.

PMID:
23495741
7.

Reliability of tumor markers, chemokines, and metastasis-related molecules in serum.

Linkov F, Gu Y, Arslan AA, Liu M, Shore RE, Velikokhatnaya L, Koenig KL, Toniolo P, Marrangoni A, Yurkovetsky Z, Zeleniuch-Jacquotte A, Lokshin AE.

Eur Cytokine Netw. 2009 Mar;20(1):21-6. doi: 10.1684/ecn.2009.0146.

8.

Head and neck squamous and thyroid carcinomas: multiplexed Luminex approaches for early detection.

Linkov F, Stack B, Yurkovetsky Z, Poveda S, Lokshin A, Ferris RL.

Expert Opin Med Diagn. 2007 Sep;1(1):129-36. doi: 10.1517/17530059.1.1.129.

PMID:
23489275
9.

Dynamic alteration of soluble serum biomarkers in healthy aging.

Shurin GV, Yurkovetsky ZR, Chatta GS, Tourkova IL, Shurin MR, Lokshin AE.

Cytokine. 2007 Aug;39(2):123-9. Epub 2007 Aug 8.

PMID:
17689975
10.

Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin.

Yurkovetsky Z, Ta'asan S, Skates S, Rand A, Lomakin A, Linkov F, Marrangoni A, Velikokhatnaya L, Winans M, Gorelik E, Maxwell GL, Lu K, Lokshin A.

Gynecol Oncol. 2007 Oct;107(1):58-65. Epub 2007 Jul 19.

11.

Biomarker approaches to the development of cancer screening tests: can cancer blood tests become a routine health check-up?

Linkov F, Yurkovetsky Z, Lokshin A.

Future Oncol. 2007 Jun;3(3):295-8. Review.

PMID:
17547524
12.

Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b.

Yurkovetsky ZR, Kirkwood JM, Edington HD, Marrangoni AM, Velikokhatnaya L, Winans MT, Gorelik E, Lokshin AE.

Clin Cancer Res. 2007 Apr 15;13(8):2422-8.

13.

Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.

Linkov F, Lisovich A, Yurkovetsky Z, Marrangoni A, Velikokhatnaya L, Nolen B, Winans M, Bigbee W, Siegfried J, Lokshin A, Ferris RL.

Cancer Epidemiol Biomarkers Prev. 2007 Jan;16(1):102-7.

14.

Multiple biomarker panels for early detection of ovarian cancer.

Yurkovetsky ZR, Linkov FY, E Malehorn D, Lokshin AE.

Future Oncol. 2006 Dec;2(6):733-41. Review.

PMID:
17155900
15.

Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies?

Shurin MR, Shurin GV, Lokshin A, Yurkovetsky ZR, Gutkin DW, Chatta G, Zhong H, Han B, Ferris RL.

Cancer Metastasis Rev. 2006 Sep;25(3):333-56. Review.

PMID:
17029028
16.
17.

Local administration of IL-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice.

Satoh Y, Esche C, Gambotto A, Shurin GV, Yurkovetsky ZR, Robbins PD, Watkins SC, Todo S, Herberman RB, Lotze MT, Shurin MR.

J Exp Ther Oncol. 2002 Nov-Dec;2(6):337-49.

PMID:
12440225
18.

Increased function and survival of IL-15-transduced human dendritic cells are mediated by up-regulation of IL-15Ralpha and Bcl-2.

Tourkova IL, Yurkovetsky ZR, Gambotto A, Makarenkova VP, Perez L, Balkir L, Robbins PD, Shurin MR, Shurin GV.

J Leukoc Biol. 2002 Nov;72(5):1037-45.

PMID:
12429727
19.

Inhibition of CD40 expression and CD40-mediated dendritic cell function by tumor-derived IL-10.

Shurin MR, Yurkovetsky ZR, Tourkova IL, Balkir L, Shurin GV.

Int J Cancer. 2002 Sep 1;101(1):61-8.

20.

Mechanisms of dendritic cell-induced T cell proliferation in the primary MLR assay.

Tourkova IL, Yurkovetsky ZR, Shurin MR, Shurin GV.

Immunol Lett. 2001 Sep 3;78(2):75-82.

PMID:
11672590
21.

Transduction of dendritic cells with Bcl-xL increases their resistance to prostate cancer-induced apoptosis and antitumor effect in mice.

Pirtskhalaishvili G, Shurin GV, Gambotto A, Esche C, Wahl M, Yurkovetsky ZR, Robbins PD, Shurin MR.

J Immunol. 2000 Aug 15;165(4):1956-64.

Supplemental Content

Loading ...
Support Center